Objectives
   
Back to Home Page

Products and applications
Membership


  CEPAD Position Papers

The following documents are made available on this site in Adobe Acrobat PDF or in MS Word :

Situation of Nonylphenol in REACH Annex XVII

Nonylphenol is not an endocrine disrupter

Mono-alkylphenols and the Preparation Directive 2006/8/EC

UK Voluntary Agreement on NP and NPE

Risk Reduction Strategy on Nonylphenol and Nonylphenol Ethoxylates, European Parliament

Biodegradability of Nonylphenol and Nonylphenol Ethoxylates

Nonylphenol and Endocrine Effects: Risks not substantiated

Press Information: Industry Views on the EU Risk Assessment of Nonylphenol

EU Risk Assessment of Nonylphenol: Industry Concerns

EU Risk Assessment of Nonylphenol and Risk Reduction Proposals: Industry Comments

EU Risk Assessment of Nonylphenol - Industry position on proposals for risk reduction 

CEPAD comments on French proposed bill 31 05 2011

CEPAD_comments_on_French_proposed_bill_31 05 2011 (French version)

CEPAD Online Comments OP SVHC 13 10 2011

CEPAD-APERC Comments OP SVHC 13 10 2011

CEPAD-APERC Comments OP SVHC - Tables A B C_Attachment

CEPAD Bulletin on ptOP SVHC Decision 02 02 2012

Final CEPAD QA about Listing ptOP as SVHC 02 02 2012

 

 

 
 
© 2000, CEPAD, All Rights Reserved, Last update on 12 March 2012